$SENS
Senseonics Holdings, Inc. Stock $sens

$sens Overview Financials Valuation SEC Filings Company Website

2022 Q2 Form 10-Q Financial Statement

#000155837022008125 Filed on May 10, 2022

Income Statement

Concept	2022 Q2	2022 Q1	2021 Q4
Revenue	$3.714M	$2.481M	$4.008M
YoY Change	12.92%	-12.83%	3.17%
Cost Of Revenue	$2.890M	$1.954M	$4.491M
YoY Change	-0.24%	-15.78%	243.09%
Gross Profit	$824.0K	$527.0K	-$483.0K
YoY Change	110.2%	0.19%	-118.75%
Gross Profit Margin	22.19%	21.24%	-12.05%
Selling, General & Admin	$8.561M	$7.883M	$5.807M
YoY Change	-6.69%	19.68%	-29.14%
% of Gross Profit	1038.96%	1495.83%
Research & Development	$9.299M	$7.804M	$7.655M
YoY Change	30.84%	48.51%
% of Gross Profit	1128.52%	1480.83%
Depreciation & Amortization	$257.0K	$263.0K	$321.0K
YoY Change	-13.18%	-16.77%	11.46%
% of Gross Profit	31.19%	49.91%
Operating Expenses	$17.86M	$15.69M	$13.46M
YoY Change	9.69%	32.47%	4.5%
Operating Profit	-$17.04M	-$15.16M	-$13.95M
YoY Change	7.21%	33.97%	35.31%
Interest Expense	$120.5M	$4.494M	$97.83M
YoY Change	2887.18%	10.74%	-228.66%
% of Operating Profit
Other Income/Expense, Net	-$52.00K	$101.9M	$553.0K
YoY Change	-99.97%	-142.77%	-104.5%
Pretax Income	$104.2M	$86.72M	$84.43M
YoY Change	-157.81%	-134.75%	-183.08%
Income Tax		$0.00
% Of Pretax Income		0.0%
Net Earnings	$104.2M	$86.72M	$84.43M
YoY Change	-157.81%	-134.75%	-183.08%
Net Earnings / Revenue	2806.44%	3495.28%	2106.61%
Basic Earnings Per Share	$0.22	$0.19
Diluted Earnings Per Share	$173.3K	-$0.03	$188.9K
COMMON SHARES
Basic Shares Outstanding	463.3M	455.9M	446.0M
Diluted Shares Outstanding	601.3M	605.2M

Balance Sheet

Concept	2022 Q2	2022 Q1	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$139.2M	$166.9M	$181.8M
YoY Change	-35.27%	-6.55%	909.65%
Cash & Equivalents	$45.43M	$39.01M	$33.46M
Short-Term Investments	$93.76M	$127.9M	$148.3M
Other Short-Term Assets	$7.499M	$7.291M	$5.775M
YoY Change	65.43%	63.81%	45.32%
Inventory	$7.251M	$7.153M	$6.316M
Prepaid Expenses
Receivables	$4.044M	$4.029M	$1.973M
Other Receivables	$319.0K	$338.0K	$443.0K
Total Short-Term Assets	$158.3M	$160.6M	$144.4M
YoY Change	-11.68%	-16.07%	377.46%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.263M	$1.320M	$1.308M
YoY Change	-9.2%	-9.77%	-15.99%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$11.33M	$25.15M	$51.88M
YoY Change	-78.17%		2650.9%
Other Assets	$4.432M	$1.055M	$1.325M
YoY Change	71.52%	-66.54%	1211.88%
Total Long-Term Assets	$17.03M	$27.52M	$54.52M
YoY Change	-69.53%	496.19%	861.12%
TOTAL ASSETS
Total Short-Term Assets	$158.3M	$160.6M	$144.4M
Total Long-Term Assets	$17.03M	$27.52M	$54.52M
Total Assets	$175.3M	$188.1M	$198.9M
YoY Change	-25.43%	-4.01%	453.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.734M	$2.089M	$1.204M
YoY Change	-42.81%	124.62%	-31.67%
Accrued Expenses	$14.41M	$12.25M	$14.26M
YoY Change	29.72%	29.68%	23.76%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$14.87M	$15.27M	$2.926M
YoY Change	158.09%	197.99%	-8.62%
Total Short-Term Liabilities	$31.47M	$31.48M	$18.39M
YoY Change	57.19%	100.69%	10.55%
LONG-TERM LIABILITIES
Long-Term Debt	$50.65M	$48.04M	$59.80M
YoY Change	-7.34%	-9.28%	4.51%
Other Long-Term Liabilities	$77.27M	$337.0K	$579.0K
YoY Change	7265.59%	-73.44%	-60.96%
Total Long-Term Liabilities	$127.9M	$337.0K	$579.0K
YoY Change	12093.99%	-73.44%	-60.96%
TOTAL LIABILITIES
Total Short-Term Liabilities	$31.47M	$31.48M	$18.39M
Total Long-Term Liabilities	$127.9M	$337.0K	$579.0K
Total Liabilities	$159.4M	$277.6M	$384.5M
YoY Change	-70.9%	-27.31%	116.98%
SHAREHOLDERS EQUITY
Retained Earnings		-$864.3M	-$951.0M
YoY Change		-3.75%	46.64%
Common Stock		$463.0K	$447.0K
YoY Change		8.18%	68.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$15.94M	-$89.47M	-$185.5M
YoY Change
Total Liabilities & Shareholders Equity	$175.3M	$188.1M	$198.9M
YoY Change	-25.43%	-4.01%	453.84%

Cashflow Statement

Concept	2022 Q2	2022 Q1	2021 Q4
OPERATING ACTIVITIES
Net Income	$104.2M	$86.72M	$84.43M
YoY Change	-157.81%	-134.75%	-183.08%
Depreciation, Depletion And Amortization	$257.0K	$263.0K	$321.0K
YoY Change	-13.18%	-16.77%	11.46%
Cash From Operating Activities	-$14.18M	-$20.16M	-$11.80M
YoY Change	0.23%	23.99%	43.1%
INVESTING ACTIVITIES
Capital Expenditures	-$74.00K	-$137.0K	-$135.0K
YoY Change	105.56%	1145.45%
Acquisitions
YoY Change
Other Investing Activities	$22.52M	$19.80M	$6.379M
YoY Change	-115.5%
Cash From Investing Activities	$22.44M	$19.67M	$6.244M
YoY Change	-115.44%	-178881.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.846M	6.043M	-7.191M
YoY Change	-103.65%	-96.58%	-11888.52%
NET CHANGE
Cash From Operating Activities	-14.18M	-20.16M	-11.80M
Cash From Investing Activities	22.44M	19.67M	6.244M
Cash From Financing Activities	-1.846M	6.043M	-7.191M
Net Change In Cash	6.414M	5.550M	-12.75M
YoY Change	-105.89%	-96.54%	55.73%
FREE CASH FLOW
Cash From Operating Activities	-$14.18M	-$20.16M	-$11.80M
Capital Expenditures	-$74.00K	-$137.0K	-$135.0K
Free Cash Flow	-$14.11M	-$20.02M	-$11.67M
YoY Change	-0.04%	23.24%	41.46%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001616543
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	447282263
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	463229779
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-37717
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	Senseonics Holdings, Inc.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-1210911
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	20451 Seneca Meadows Parkway
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Germantown
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20876-7005
CY2022Q1	dei	City Area Code CityAreaCode	301
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	515-7260
CY2022Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
CY2022Q1	dei	Trading Symbol TradingSymbol	SENS
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	463263499
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39011000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33461000
CY2022Q1	us-gaap	Short Term Investments ShortTermInvestments	102755000
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	96445000
CY2022Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	232000
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	205000
CY2022Q1	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	3797000
CY2021Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	1768000
CY2022Q1	us-gaap	Inventory Net InventoryNet	7153000
CY2021Q4	us-gaap	Inventory Net InventoryNet	6316000
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7629000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6218000
CY2022Q1	us-gaap	Assets Current AssetsCurrent	160577000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	144413000
CY2022Q1	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	269000
CY2021Q4	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	239000
CY2022Q1	sens	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	786000
CY2021Q4	sens	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	1086000
CY2022Q1	us-gaap	Long Term Investments LongTermInvestments	25145000
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	51882000
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1320000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1308000
CY2022Q1	us-gaap	Assets Assets	188097000
CY2021Q4	us-gaap	Assets Assets	198928000
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2089000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1204000
CY2022Q1	sens	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	8742000
CY2021Q4	sens	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	10667000
CY2022Q1	sens	Accrued Liabilities And Other Liabilities Current From Related Parties AccruedLiabilitiesAndOtherLiabilitiesCurrentFromRelatedParties	3674000
CY2021Q4	sens	Accrued Liabilities And Other Liabilities Current From Related Parties AccruedLiabilitiesAndOtherLiabilitiesCurrentFromRelatedParties	3597000
CY2022Q1	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	14534000
CY2022Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1713000
CY2022Q1	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	732000
CY2021Q4	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	2926000
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	31484000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	18394000
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	48035000
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	59798000
CY2022Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	150010000
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	236291000
CY2022Q1	sens	Long Term Options LongTermOptions	47700000
CY2021Q4	sens	Long Term Options LongTermOptions	69401000
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	337000
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	579000
CY2022Q1	us-gaap	Liabilities Liabilities	277566000
CY2021Q4	us-gaap	Liabilities Liabilities	384463000
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	463229779
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	447282263
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	463000
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	447000
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	775172000
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	765215000
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-837000
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-212000
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-864267000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-950985000
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-89469000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-185535000
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	188097000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	198928000
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	292000
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	487000
CY2022Q1	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	2189000
CY2021Q1	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	2359000
CY2022Q1	us-gaap	Revenues Revenues	2481000
CY2021Q1	us-gaap	Revenues Revenues	2846000
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1954000
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2320000
CY2022Q1	us-gaap	Gross Profit GrossProfit	527000
CY2021Q1	us-gaap	Gross Profit GrossProfit	526000
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1509000
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1613000
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7804000
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5255000
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6374000
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4974000
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-15160000
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-11316000
CY2022Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	93000
CY2021Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	9000
CY2022Q1	sens	Nonoperating Gain Loss Fair Value Adjustment NonoperatingGainLossFairValueAdjustment	21701000
CY2021Q1	sens	Nonoperating Gain Loss Fair Value Adjustment NonoperatingGainLossFairValueAdjustment	-52675000
CY2021Q1	sens	Gains Losses On Extinguishment Of Debt And Gain Loss On Stock Conversion GainsLossesOnExtinguishmentOfDebtAndGainLossOnStockConversion	330000
CY2022Q1	us-gaap	Interest Expense InterestExpense	4494000
CY2021Q1	us-gaap	Interest Expense InterestExpense	4058000
CY2022Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	84569000
CY2021Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-180899000
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	-30000
CY2021Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	782000
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-21000
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-123000
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	101878000
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-238198000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	86718000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-249514000
CY2022Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-625000
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-625000
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	86093000
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-249514000
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.68
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	455942886
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	364274433
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.68
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	605198839
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	364274433
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-144083000
CY2021Q1	sens	Shares Issued During Period Value Conversion Of Temporary Equity SharesIssuedDuringPeriodValueConversionOfTemporaryEquity	45567000
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	152087000
CY2021Q1	sens	Exercise Of Stock Options Vesting Of Rs Us And Espp Purchases ExerciseOfStockOptionsVestingOfRSUsAndESPPPurchases	1699000
CY2021Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	6501000
CY2021Q1	sens	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options And Restricted Stock Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAndRestrictedStockRequisiteServicePeriodRecognition	1844000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-249514000
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-185899000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-185535000
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	8004000
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	171000
CY2022Q1	sens	Issued Common Stock For Vested Rsus And Espp Purchase IssuedCommonStockForVestedRsusAndEsppPurchase	62000
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1736000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	86718000
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-625000
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-89469000
CY2022Q1	us-gaap	Profit Loss ProfitLoss	86718000
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-249514000
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	263000
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	316000
CY2022Q1	sens	Amortization Of Financing Costs Discounts And Deferred Costs AmortizationOfFinancingCostsDiscountsAndDeferredCosts	2772000
CY2021Q1	sens	Amortization Of Financing Costs Discounts And Deferred Costs AmortizationOfFinancingCostsDiscountsAndDeferredCosts	972000
CY2022Q1	sens	Fair Value Adjustment Derivative Liability FairValueAdjustmentDerivativeLiability	-84569000
CY2021Q1	sens	Fair Value Adjustment Derivative Liability FairValueAdjustmentDerivativeLiability	180899000
CY2022Q1	sens	Nonoperating Gain Loss Fair Value Adjustment NonoperatingGainLossFairValueAdjustment	21701000
CY2021Q1	sens	Nonoperating Gain Loss Fair Value Adjustment NonoperatingGainLossFairValueAdjustment	-52675000
CY2021Q1	sens	Gains Losses On Extinguishment Of Debt And Gain Loss On Stock Conversion GainsLossesOnExtinguishmentOfDebtAndGainLossOnStockConversion	330000
CY2022Q1	sens	Impairment Of Options ImpairmentOfOptions	-30000
CY2021Q1	sens	Impairment Of Options ImpairmentOfOptions	782000
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1736000
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1740000
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2056000
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1301000
CY2022Q1	sens	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	1411000
CY2021Q1	sens	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	677000
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	837000
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1303000
CY2022Q1	sens	Increase Decrease In Deposit Assets And Other Assets IncreaseDecreaseInDepositAssetsAndOtherAssets	-163000
CY2021Q1	sens	Increase Decrease In Deposit Assets And Other Assets IncreaseDecreaseInDepositAssetsAndOtherAssets	30000
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	886000
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-833000
CY2022Q1	sens	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	-2031000
CY2021Q1	sens	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	-3411000
CY2022Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-62000
CY2021Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1155000
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20159000
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16258000
CY2022Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	137000
CY2021Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	11000
CY2022Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	19803000
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	19666000
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11000
CY2022Q1	sens	Proceeds From Issuance Of Common Stock Net ProceedsFromIssuanceOfCommonStockNet	8004000
CY2021Q1	sens	Proceeds From Issuance Of Common Stock Net ProceedsFromIssuanceOfCommonStockNet	152087000
CY2022Q1	sens	Proceeds From Exercise Of Stock Options Stock Warrants And Espp Purchases ProceedsFromExerciseOfStockOptionsStockWarrantsAndEsppPurchases	233000
CY2021Q1	sens	Proceeds From Exercise Of Stock Options Stock Warrants And Espp Purchases ProceedsFromExerciseOfStockOptionsStockWarrantsAndEsppPurchases	1804000
CY2021Q1	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	22783000
CY2022Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	2194000
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6043000
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	176674000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5550000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	160405000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33461000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18205000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39011000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	178610000
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	1762000
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	1927000
CY2021Q1	sens	Common Stock Issued Converted From Preferred Shares CommonStockIssuedConvertedFromPreferredShares	54166000
CY2021Q1	sens	Common Stock Issued1 CommonStockIssued1	4925000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-302500000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-175200000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-115500000
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-864300000
CY2022Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	166900000
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-weight:bold;visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenue and expenses during the reporting period. In the accompanying unaudited consolidated financial statements, estimates are used for, but not limited to, stock-based compensation, recoverability of long-lived assets, deferred taxes and valuation allowances, derivative assets and liabilities, obsolete inventory, warranty obligations, variable consideration related to revenue, depreciable lives of property and equipment, and accruals for clinical study costs, which are accrued based on estimates of work performed under contract. The Company considered COVID-19 related impacts to its estimates, as appropriate, within its unaudited condensed consolidated financial statements and there may be changes to those estimates in future periods due to the uncertainties surrounding the severity and duration of the COVID-19 pandemic. Actual results could differ from those estimates.</p>
CY2022Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2022Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-600000
CY2022Q1	us-gaap	Cash Cash	1338000
CY2021Q4	us-gaap	Cash Cash	4264000
CY2022Q1	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	37673000
CY2021Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	29197000
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39011000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33461000
CY2022Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2022Q1	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:14pt 0pt 0pt 0pt;"><span style="font-style:italic;font-weight:bold;">Warranty Obligation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-indent:36pt;margin:14pt 0pt 0pt 0pt;"><span style="font-size:10pt;">The Company provides a warranty of </span><span style="font-size:10pt;">one year</span><span style="font-size:10pt;"> on its smart transmitters. Additionally, the Company may also replace Eversense system components that do not function in accordance with the product specifications. Estimated replacement costs are recorded at the time of shipment as a charge to cost of sales in the consolidated statement of operations and are developed by analyzing product performance data and historical replacement experience, including comparing actual replacements to revenue.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-indent:36pt;margin:14pt 0pt 0pt 0pt;"><span style="font-size:10pt;">At March 31, 2022, and December 31, 2021, the warranty reserve was </span><span style="font-size:10pt;">$0.8</span><span style="font-size:10pt;"> million and </span><span style="font-size:10pt;">$0.7</span><span style="font-size:10pt;"> million, respectively. </span><span style="font-size:10pt;">The following table provides a reconciliation of the change in estimated warranty liabilities for the three months ended March 31, 2022 and for the twelve months ended December 31, 2021 (in thousands):</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;"></span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:52.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:21.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;"></span></p></div></div></td></tr><tr><td style="vertical-align:middle;white-space:nowrap;width:52.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="vertical-align:middle;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:23.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;margin-bottom:0pt;visibility:hidden;"></span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:52.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-style:italic;margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="vertical-align:middle;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"> </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:23.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"> </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">Balance at beginning of the period</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> 723</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> 646</p></td></tr><tr><td style="vertical-align:bottom;width:52.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">Provision for warranties during the period</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> 58</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> 781</p></td></tr><tr><td style="vertical-align:bottom;width:52.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">Settlements made during the period</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.82%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (3)</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.76%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (704)</p></td></tr><tr><td style="vertical-align:bottom;width:52.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">Balance at end of the period</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.82%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> 778</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.76%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> 723</p></td></tr></table>
CY2022Q1	sens	Product Warranty Term ProductWarrantyTerm	P1Y
CY2022Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	800000
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	700000
CY2021Q4	sens	Unbilled Accounts Receivable UnbilledAccountsReceivable	1800000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	86718000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-249514000
CY2022Q1	us-gaap	Dilutive Securities DilutiveSecurities	-104575000
CY2022Q1	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-17857000
CY2021Q1	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-249514000
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	723000
CY2020Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	646000
CY2022Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	58000
CY2021	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	781000
CY2022Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	3000
CY2021	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	704000
CY2022Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	778000
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	723000
CY2022Q1	sens	Number Of Geographical Markets NumberOfGeographicalMarkets	2
CY2022Q1	us-gaap	Time Sharing Transactions Allowance For Uncollectible Accounts TimeSharingTransactionsAllowanceForUncollectibleAccounts	0
CY2021Q4	us-gaap	Time Sharing Transactions Allowance For Uncollectible Accounts TimeSharingTransactionsAllowanceForUncollectibleAccounts	0
CY2022Q1	sens	Unbilled Accounts Receivable UnbilledAccountsReceivable	700000
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.68
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.68
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	455942886
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	364274433
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	8982055
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	5685919
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	605198839
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	364274433
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	35015905
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	154031304
CY2022Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	128737000
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	837000
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	127900000
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	148539000
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	212000
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	148327000
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue	77905000
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	45372000
CY2022Q1	sens	Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Year One Through Two DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo	2445000
CY2022Q1	sens	Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Year Two DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearTwo	3015000
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	128737000
CY2022Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1203000
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1012000
CY2022Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	4381000
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3770000
CY2022Q1	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	1569000
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	1534000
CY2022Q1	us-gaap	Inventory Net InventoryNet	7153000
CY2021Q4	us-gaap	Inventory Net InventoryNet	6316000
CY2022Q1	sens	Prepaid Contract Manufacturing Current PrepaidContractManufacturingCurrent	5016000
CY2021Q4	sens	Prepaid Contract Manufacturing Current PrepaidContractManufacturingCurrent	5036000
CY2022Q1	us-gaap	Prepaid Insurance PrepaidInsurance	1404000
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	74000
CY2022Q1	sens	Prepaid Clinical And Preclinical Costs PrepaidClinicalAndPreclinicalCosts	467000
CY2021Q4	sens	Prepaid Clinical And Preclinical Costs PrepaidClinicalAndPreclinicalCosts	142000
CY2022Q1	us-gaap	Interest Receivable Current InterestReceivableCurrent	338000
CY2021Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	443000
CY2022Q1	sens	Prepaid Information Technology And Software Costs Current PrepaidInformationTechnologyAndSoftwareCostsCurrent	180000
CY2021Q4	sens	Prepaid Information Technology And Software Costs Current PrepaidInformationTechnologyAndSoftwareCostsCurrent	225000
CY2022Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	119000
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	193000
CY2022Q1	us-gaap	Prepaid Rent PrepaidRent	105000
CY2021Q4	us-gaap	Prepaid Rent PrepaidRent	105000
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7629000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6218000
CY2021Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1771000
CY2021Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2217000
CY2021Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	67000
CY2021Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3183000
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1811000
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3484000
CY2022Q1	sens	Accrued Research And Development Current AccruedResearchAndDevelopmentCurrent	1781000
CY2021Q4	sens	Accrued Research And Development Current AccruedResearchAndDevelopmentCurrent	2145000
CY2022Q1	us-gaap	Interest Payable Current InterestPayableCurrent	2083000
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	2144000
CY2022Q1	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	2078000
CY2021Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	1962000
CY2022Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1753000
CY2021Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1697000
CY2022Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1039000
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1011000
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	981000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	904000
CY2022Q1	sens	Accrued Contract Manufacturing Costs Current AccruedContractManufacturingCostsCurrent	727000
CY2021Q4	sens	Accrued Contract Manufacturing Costs Current AccruedContractManufacturingCostsCurrent	914000
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	163000
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3000
CY2022Q1	sens	Accrued Liabilities And Other Liabilities Including Related Party Current AccruedLiabilitiesAndOtherLiabilitiesIncludingRelatedPartyCurrent	12416000
CY2021Q4	sens	Accrued Liabilities And Other Liabilities Including Related Party Current AccruedLiabilitiesAndOtherLiabilitiesIncludingRelatedPartyCurrent	14264000
CY2022Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1700000
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2683000
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	87000
CY2022Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	4470000
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2021Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	7238000
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	732000
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	15700000
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	35000000
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	51199000
CY2022Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	102631000
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0

Files In Submission

Name	View Source	Status
0001558370-22-008125-index-headers.html	Edgar Link	pending
0001558370-22-008125-index.html	Edgar Link	pending
0001558370-22-008125.txt	Edgar Link	pending
0001558370-22-008125-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sens-20220331.xsd	Edgar Link	pending
sens-20220331x10q.htm	Edgar Link	pending
sens-20220331x10q_htm.xml	Edgar Link	completed
sens-20220331xex31d1.htm	Edgar Link	pending
sens-20220331xex31d2.htm	Edgar Link	pending
sens-20220331xex32d1.htm	Edgar Link	pending
sens-20220331_cal.xml	Edgar Link	unprocessable
sens-20220331_def.xml	Edgar Link	unprocessable
sens-20220331_lab.xml	Edgar Link	unprocessable
sens-20220331_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SENS
Senseonics Holdings, Inc. Stock $sens

2022 Q2 Form 10-Q Financial Statement

#000155837022008125 Filed on May 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SENS Senseonics Holdings, Inc. Stock $sens

2022 Q2 Form 10-Q Financial Statement

#000155837022008125 Filed on May 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SENS
Senseonics Holdings, Inc. Stock $sens